RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice
2021 Meregalli, C; Bonomo, R; Cavaletti, G; Carozzi, V
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy
2021 Pero, M; Meregalli, C; Qu, X; Shin, G; Kumar, A; Shorey, M; Rolls, M; Tanji, K; Brannagan, T; Alberti, P; Fumagalli, G; Monza, L; Grueber, W; Cavaletti, G; Bartolini, F
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity
2021 Meregalli, C; Monza, L; Chiorazzi, A; Scali, C; Guarnieri, C; Fumagalli, G; Alberti, P; Pozzi, E; Canta, A; Ballarini, E; Rodriguez-Menendez, V; Oggioni, N; Cavaletti, G; Marmiroli, P
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118)
2021 Pero, M; Meregalli, C; Qu, X; Ji-Eun Shin, G; Kumar, A; Shorey, M; Rolls, M; Tanji, K; Brannagan, T; Alberti, P; Fumagalli, G; Monza, L; Grueber, W; Cavaletti, G; Bartolini, F
Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy
2021 Eldridge, S; Scuteri, A; Jones, E; Cavaletti, G; Guo, L; Glaze, E
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect
2021 Malacrida, A; Semperboni, S; Di Domizio, A; Palmioli, A; Broggi, L; Airoldi, C; Meregalli, C; Cavaletti, G; Nicolini, G
The Italian law on body donation: A position paper of the Italian College of Anatomists
2021 De Caro, R; Boscolo-Berto, R; Artico, M; Bertelli, E; Cannas, M; Cappello, F; Carpino, G; Castorina, S; Cataldi, A; Cavaletti, G; Cinti, S; Cocco, L; Cremona, O; Crivellato, E; De Luca, A; Falconi, M; Familiari, G; Ferri, G; Fornai, F; Gesi, M; Geuna, S; Gibelli, D; Giordano, A; Gobbi, P; Guerra, G; Gulisano, M; Macchi, V; Macchiarelli, G; Manzoli, L; Michetti, F; Miscia, S; Montagnani, S; Montella, A; Morini, S; Onori, P; Palumbo, C; Papa, M; Porzionato, A; Quacci, D; Raspanti, M; Rende, M; Rezzani, R; Ribatti, D; Ripani, M; Rodella, L; Rossi, P; Sbarbati, A; Secchiero, P; Sforza, C; Stecco, C; Toni, R; Vercelli, A; Vitale, M; Zancanaro, C; Zauli, G; Zecchi, S; Anastasi, G; Gaudio, E
Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy Induced Peripheral Neurotoxicity
2021 Alberti, P; Bernasconi, D; Cornblath, D; Jose Merkies, I; Park, S; Velasco, R; Bruna, J; Psimaras, D; Susanne, K; Pace, A; Dorsey, S; Argyriou, A; Kalofonos, H; Briani, C; Schenone, A; Faber, C; Mazzeo, A; Grisold, W; Valsecchi, M; Cavaletti, G
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy
2021 Fumagalli, G; Monza, L; Cavaletti, G; Rigolio, R; Meregalli, C
In vitro evaluation of rigosertib antitumoral and radiosensitizing effects against human cholangiocarcinoma cells
2021 Malacrida, A; Rigolio, R; Celio, L; Damian, S; Cavaletti, G; Mazzaferro, V; Miloso, M
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY
2021 Malacrida, A; Semperboni, S; Di Domizio, A; Pamioli, A; Airoldi, C; Meregalli, C; Cavaletti, G; Nicolini, G
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN
2021 Alberti, P; Canta, A; Chiorazzi, A; Meregalli, C; Monza, L; Pozzi, E; Ballarini, E; Rodriguez Menendez, V; Marmiroli, P; Cavaletti, G
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY
2021 Pozzi, E; Ballarini, E; Rodriguez Menendez, V; Alberti, P; Canta, A; Monza, L; Malacrida, A; Scuteri, A; Cavaletti, G; Carozzi, V
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register
2021 Lepore, V; Bosetti, C; Santucci, C; Iaffaldano, P; Trojano, M; Mosconi, P; Totaro, R; Coniglio, M; Bossio, R; Valentino, P; Gatto, M; Paolicelli, D; Ardito, B; Barcella, V; Capone, L; Nicolao, P; Lugaresi, A; Rini, A; Bianchi, M; Plasmati, I; Cocco, E; Docimo, R; De Luca, G; Mondino, F; Di Sapio, A; Clerici, R; Mascoli, N; Ferro, M; Chisari, C; Maimone, D; Strumia, S; Pugliatti, M; Cargnelutti, D; Caniatti, L; Avolio, C; Crociani, P; Amato, M; Massacesi, L; Malagu, S; Ribizzi, G; Inglese, M; Venturi, S; Gazzola, P; Pizio, N; Brichetto, G; Plewnia, K; Bellantonio, P; Balgera, R; De Robertis, F; Fermi, S; Fausto, F; Mazzoni, M; Meucci, G; Cartechini, E; Cavaletti, G; Buccafusca, M; Bramanti, P; Romeo, M; Rovaris, M; Ronzoni, M; Confalonieri, P; Chiveri, L; Bertora, P; Tonietti, S; De Riz, M; Protti, A; Sola, P; Maremmani, C; Lus, G; Gallo, A; Maniscalco, G; Morra, V; Cacchio, G; Iodice, R; Ragno, M; Sinisi, L; Cantello, R; Piras, M; Salemi, G; Cottone, S; Grimaldi, L; Corea, F; Santangelo, G; Immovili, P; Gallo, P; D'Andrea, F; Frittelli, C; Pasquali, L; Falcini, M; Granella, F; Pesci, I; Ancona, A; Bergamaschi, R; Giordano, A; Di Napoli, M; Romano, S; Pozzilli, C; Mirabella, M; Conte, A; Galgani, S; Peresson, M; Grasso, M; Ferraro, E; Capone, F; Marfia, G; de Pascalis, D; Piantadosi, C; Valeriani, M; Busillo, V; Barone, P; De Stefano, N; Ulivelli, M; Santuccio, G; Parodi, S; Bucello, S; Traccis, S; Zarbo, R; Tassinari, T; Bandini, F; Cavalla, P; Clerico, M; De Rosa, G; Bertolotto, A; Imperiale, D; Sarchielli, P; Celani, M; Vianello, M; Marini, B; Fortunato, M; Zaffaroni, M; Nasuelli, D; Banfi, P; Brioschi, A; Solaro, C; Quatrale, R; Rossi, P; Gajofatto, A; Trojano, M; Battaglia, M; Capobianco, M; Pugliatti, M; Ulivelli, M; Mosconi, P; Patti, F; Amato, M; Bergamaschi, R; Comi, G
Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis
2021 Baroncini, D; Simone, M; Iaffaldano, P; Brescia Morra, V; Lanzillo, R; Filippi, M; Romeo, M; Patti, F; Chisari, C; Cocco, E; Fenu, G; Salemi, G; Ragonese, P; Inglese, M; Cellerino, M; Margari, L; Comi, G; Zaffaroni, M; Ghezzi, A; Cavaletti, G
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model.
2021 Alberti, P; Bontempi, P; Gerevini, S; Napolitani, A; Daducci, A; Schiavi, S; Canta, A; Chiorazzi, A; Fumagalli, G; Monza, L; Pozzi, E; Marzola, P; Cavaletti, G; Stefano, T
INVESTIGATION OF AGING EFFECTS ON NERVE DAMAGE IN AN ANIMAL MODEL OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY
2021 Bonomo, R; Canta, A; Chiorazzi, A; Carozzi, V; Pozzi, E; Alberti, P; Van Der Veen, D; Marmiroli, P; Skene, D; Cavaletti, G
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: An international observational study
2021 Verboon, C; Harbo, T; Cornblath, D; Hughes, R; Van Doorn, P; Lunn, M; Gorson, K; Barroso, F; Kuwabara, S; Galassi, G; Lehmann, H; Kusunoki, S; Reisin, R; Binda, D; Cavaletti, G; Jacobs, B
Alterations of gut microbiota composition in post-finasteride patients: a pilot study
2021 Borgo, F; Macandog, A; Diviccaro, S; Falvo, E; Giatti, S; Cavaletti, G; Melcangi, R
Nerve pathology in animal models of neuropathies
2021 Carozzi, V; Bolino, A; D'Antonio, M; Quattrini, A; Cavaletti, G
High-spatial-resolution three-dimensional imaging of human spinal cord and column anatomy with postmortem x-ray phase-contrast micro-CT
2021 Barbone, G; Bravin, A; Mittone, A; Grosu, S; Ricke, J; Cavaletti, G; Djonov, V; Coan, P
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery.
2020 Alberti, P; Ballarini, E; Canta, A; Chiorazzi, A; Fumagalli, G; Malacrida, A; Meregalli, C; Monza, L; Pozzi, E; Marmiroli, P; Cavaletti, G
A possible biomarker for paclitaxel-induced peripheral neurotoxicity: Neurofilament light chain serum levels monitoring
2020 Alberti, P; Cicchiello, F; Riva, F; Cavaletti, G; Cazzaniga, M
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back.
2020 Alberti, P; Ballarini, E; Canta, A; Chiorazzi, A; Fumagalli, G; Malacrida, A; Monza, L; Pozzi, E; Meregalli, C; Marmiroli, P; Cavaletti, G
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents
2020 Listro, R; Stotani, S; Rossino, G; Rui, M; Malacrida, A; Cavaletti, G; Cortesi, M; Arienti, C; Tesei, A; Rossi, D; Giacomo, M; Miloso, M; Collina, S
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Keyword
- Humans 80
- neurotoxicity 76
- Female 63
- Animals 61
- neuropathy 52
- Rats 45
- Peripheral Nervous System Diseases 41
- peripheral neuropathy 39
- Male 38
- Cisplatin 36
Rivista
- JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 119
- NEUROLOGICAL SCIENCES 18
- NEUROLOGY 16
- EXPERIMENTAL NEUROLOGY 12
- ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY 12
- ANTICANCER RESEARCH 11
- CURRENT MEDICINAL CHEMISTRY 11
- JOURNAL OF NEUROIMMUNOLOGY 10
- JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY 10
- ANNALS OF ONCOLOGY 9
Editore
- Elsevier 32
- MDPI AG 16
- Wiley-Blackwell Publishing, Inc. 14
- Woodland Publications 14
- Blackwell Publishing Inc. 11
- MDPI 10
- Bentham Science Publishers 9
- Elsevier B.V. 9
- Pergamon 9
- Springer 9
Lingua
- eng 691
- ita 5
Settore disciplinare
- BIO/16 - ANATOMIA UMANA 126
- MED/26 - NEUROLOGIA 11
- BIO/17 - ISTOLOGIA 4
- MED/40 - GINECOLOGIA E OSTETRICIA 4
- BIO/09 - FISIOLOGIA 2
- BIO/10 - BIOCHIMICA 2
- FIS/07 - FISICA APPLICATA (A BENI CULTURALI, AMBIENTALI, BIOLOGIA E MEDICINA) 2
- MED/06 - ONCOLOGIA MEDICA 2
- MED/27 - NEUROCHIRURGIA 2
- CHIM/06 - CHIMICA ORGANICA 1
Tipologia
- 01 - Articolo su rivista 425
- 02 - Intervento a convegno 251
- 03 - Contributo in libro 14
- 05 - Curatele 2
- 99 - Altro 2
- 01b - Traduzione su rivista 1
- 04 - Monografia 1
Accesso al fulltext
- no fulltext 508
- open 133
- reserved 49
- partially open 6
Progetto
- - 4
- NAD 1